- Home
- MRVI vs RFMZ Comparison
MRVI vs RFMZ Comparison
Compare MRVI & RFMZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRVI
- RFMZ
- Stock Information
- Founded
- MRVI 2014
- RFMZ 2021
- Country
- MRVI United States
- RFMZ United States
- Employees
- MRVI 560
- RFMZ N/A
- Industry
- MRVI Biotechnology: Pharmaceutical Preparations
- RFMZ Trusts Except Educational Religious and Charitable
- Sector
- MRVI Health Care
- RFMZ Finance
- Exchange
- MRVI Nasdaq
- RFMZ Nasdaq
- Market Cap
- MRVI 350.1M
- RFMZ 310.1M
- IPO Year
- MRVI 2020
- RFMZ N/A
- Fundamental
- Price
- MRVI $2.42
- RFMZ $12.54
- Analyst Decision
- MRVI Hold
- RFMZ
- Analyst Count
- MRVI 10
- RFMZ 0
- Target Price
- MRVI $5.84
- RFMZ N/A
- AVG Volume (30 Days)
- MRVI 1.5M
- RFMZ 76.6K
- Earning Date
- MRVI 08-11-2025
- RFMZ 01-01-0001
- Dividend Yield
- MRVI N/A
- RFMZ 7.43%
- EPS Growth
- MRVI N/A
- RFMZ N/A
- EPS
- MRVI N/A
- RFMZ 0.65
- Revenue
- MRVI $219,830,000.00
- RFMZ N/A
- Revenue This Year
- MRVI N/A
- RFMZ N/A
- Revenue Next Year
- MRVI $7.23
- RFMZ N/A
- P/E Ratio
- MRVI N/A
- RFMZ $21.49
- Revenue Growth
- MRVI N/A
- RFMZ N/A
- 52 Week Low
- MRVI $1.67
- RFMZ $11.28
- 52 Week High
- MRVI $9.60
- RFMZ $14.57
- Technical
- Relative Strength Index (RSI)
- MRVI 49.60
- RFMZ 44.54
- Support Level
- MRVI $2.28
- RFMZ $12.45
- Resistance Level
- MRVI $2.47
- RFMZ $12.61
- Average True Range (ATR)
- MRVI 0.14
- RFMZ 0.13
- MACD
- MRVI -0.01
- RFMZ -0.02
- Stochastic Oscillator
- MRVI 27.45
- RFMZ 13.24
About MRVI Maravai LifeSciences Holdings Inc.
Maravai LifeSciences Holdings Inc is a life sciences company that provides critical products that drive the development of groundbreaking vaccines, drug therapies, cell and gene therapies, and diagnostics. The group's solutions empower research into human diseases and support the entire biopharmaceutical development process from early discovery to commercialization. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.
About RFMZ RiverNorth Flexible Municipal Income Fund II Inc.
RiverNorth Flex Muni Income Fund II Inc is a diversified, closed-end management investment company. Its primary investment objective is to seek current income exempt from regular U.S. federal income taxes. The fund's secondary investment objective is total return.